Papaverine 40 mg/ml Injection recall: Sterility Concern
Papaverine 40 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Why was Papaverine 40 mg/ml Injection recalled?
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
What should I do if I have this product?
The recall is ongoing. Follow the firm and FDA instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
B0021 Exp 8/31/13, B0013 Exp 8/1/13, C5122 Exp 9/22/13, C51101 Exp 8/1/13, C5508 Exp 9/8/13, and C5119 Exp 9/19/13
- Product
- Papaverine 40 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
- Recalling firm
- Lowlite Investments, Inc. D/B/A Olympia Pharmacy
- Quantity
- 6
- Distribution
- Nationwide and PR
- Recall date
- July 17, 2013
- Classification
- Class II
- Status
- Ongoing
- Agency
- FDA (drug)